Improving Cardiac Delivery of Antisense Oligonucleotides with Peptidomimetic Targeting Agents
Cardiovascular disease (CVD) is one of the leading causes of death worldwide, both individually and as a comorbidity for other diseases such as diabetes and atherosclerosis. Unfortunately, CVD trends irreversibly toward heart failure. Current treatments only manage symptoms such as high blood pressu...
Main Author: | |
---|---|
Other Authors: | |
Format: | Thesis |
Published: |
Massachusetts Institute of Technology
2023
|
Online Access: | https://hdl.handle.net/1721.1/153070 |